Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailAccess to healthcare will remain a priority for the US, says Biocon CEOPeter Bains, Group CEO of Biocon, talks about how the India-based pharmaceutical company is placed ahead of a second Trump presidency, as well as the development of its weight-loss and anti-obesity drug.
Persons:
Peter Bains
Organizations:
Biocon, Trump
Locations:
India